98%
921
2 minutes
20
Leukoencephalopathy with vanishing white matter (LVWM) is an autosomal recessive disease. Ovarioleukodystrophy is defined as LVWM in females showing signs or symptoms of gradual ovarian failure. We present a 38-year-old female with ovarioleukodystrophy who showed status epilepticus, gait instability, slurred speech, abdominal tendon hyperreflexia, and ovarian failure. Abnormal EEG, characteristic magnetic resonance, and unreported EIF2B5 compound heterozygous mutations [c.1016G>A (p.R339Q) and c.1157G>A (p.G386D)] were found. Furthermore, the present report summarizes 20 female patients with adult-onset ovarioleukodystrophy and EIF2B5 gene mutations. In conclusion, a new genetic locus for LVWM was discovered. Compared with previous cases, mutations at different EIF2B5 sites might have different clinical manifestations and obvious clinical heterogeneity.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243765 | PMC |
http://dx.doi.org/10.3389/fneur.2022.813032 | DOI Listing |
Orphanet J Rare Dis
August 2025
Department of Pediatric Neurology, Emma Children's Hospital, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Background: Vanishing White matter (VWM) is one of the more prevalent leukodystrophies, caused by biallelic pathogenic variants in any of the EIF2B1-5 genes. It is characterized by chronic progressive neurological deterioration and additional stress-provoked episodes of rapid decline, leading to severe neurological impairment and early death. The impact of VWM on unaffected family members has not been investigated.
View Article and Find Full Text PDFFront Pediatr
August 2025
Department of Clinical Genetics, Odense Universitetshospital, Odense, Denmark.
Introduction: Vanishing White Matter disease (VWM) is a rare neurological disease, with an autosomal recessive inheritance. In this case report, we describe two four-year-old dizygotic twin brothers diagnosed with VWM with the same genotype and different phenotypes. We also describe a new likely pathogenic variant leading to VWM.
View Article and Find Full Text PDFBMJ Case Rep
August 2025
Neurology Department, Hospital Pedro Hispano, Matosinhos, Porto, Portugal.
Vanishing white matter disease (VWMD) is typically diagnosed in childhood or early adulthood. Here, we report a case of a woman in her early 70s presenting with new-onset seizures and rapidly progressive cognitive and motor decline. Brain MRI revealed diffuse white matter rarefaction with cystic degeneration, and genetic testing identified compound heterozygosity in the EIF2B5 gene (p.
View Article and Find Full Text PDFBrain Dev
July 2025
Department of Child Neurology, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8551, Japan. Electronic address:
We reviewed published articles on representative inherited cerebral white matter disorders that develop in childhood. In this paper, we described demyelinating disorders (adrenoleukodystrophy, globoid cell leukodystrophy or Krabbe disease, and metachromatic leukodystrophy), astrocytic disorders (Alexander disease and vanishing white matter disease), and disorders of water homeostasis in the myelin sheath (megalencephalic leukoencephalopathy with subcortical cysts and CLCN2-related leukoencephalopathy). The causes, symptoms, diagnostic imaging, and forefront of treatment for these disorders are discussed.
View Article and Find Full Text PDFIndian J Otolaryngol Head Neck Surg
August 2025
ENT- Head and Neck Surgery Departement, Hospital of Specialties, Mohammed V University, Rabat, Morocco.
Childhood Ataxia with Central nervous system Hypomyelination, also known as leukoencephalopathy with Vanishing white matter, is a rare genetic disorder of autosomal recessive transmission, belonging to the hypomyelinating leukodystrophy family. It is characterized by progressive degradation of cerebral white matter, leading to cerebellar ataxia, various cognitive disorders, and muscle stiffness, as well as deafness. The diagnosis is made on the basis of a combination of clinical and radiological evidence, together with the identification of a mutation in the Eukaryotic Initiation Factor-2B gene.
View Article and Find Full Text PDF